Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 155

1.

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.

Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T.

J Clin Invest. 1999 May;103(9):1345-52.

PMID:
10225978
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation.

Suda K, Udagawa N, Sato N, Takami M, Itoh K, Woo JT, Takahashi N, Nagai K.

J Immunol. 2004 Feb 15;172(4):2504-10.

PMID:
14764723
[PubMed - indexed for MEDLINE]
Free Article
3.

alpha-Lipoic acid inhibits inflammatory bone resorption by suppressing prostaglandin E2 synthesis.

Ha H, Lee JH, Kim HN, Kim HM, Kwak HB, Lee S, Kim HH, Lee ZH.

J Immunol. 2006 Jan 1;176(1):111-7.

PMID:
16365401
[PubMed - indexed for MEDLINE]
Free Article
4.

Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2.

Koide M, Murase Y, Yamato K, Noguchi T, Okahashi N, Nishihara T.

Biochem Biophys Res Commun. 1999 May 27;259(1):97-102.

PMID:
10334922
[PubMed - indexed for MEDLINE]
5.

Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.

Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T.

Bone. 1999 Nov;25(5):517-23.

PMID:
10574571
[PubMed - indexed for MEDLINE]
6.

Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.

Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, Koshihara Y, Oda H, Nakamura K, Tanaka S.

Arthritis Rheum. 2000 Feb;43(2):259-69.

PMID:
10693864
[PubMed - indexed for MEDLINE]
Free Article
7.

Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells.

Nakagawa N, Yasuda H, Yano K, Mochizuki Si, Kobayashi N, Fujimoto H, Shima N, Morinaga T, Chikazu D, Kawaguchi H, Higashio K.

Biochem Biophys Res Commun. 1999 Nov;265(1):158-63.

PMID:
10548507
[PubMed - indexed for MEDLINE]
8.

Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.

Kotake S, Sato K, Kim KJ, Takahashi N, Udagawa N, Nakamura I, Yamaguchi A, Kishimoto T, Suda T, Kashiwazaki S.

J Bone Miner Res. 1996 Jan;11(1):88-95.

PMID:
8770701
[PubMed - indexed for MEDLINE]
9.

A novel molecular mechanism modulating osteoclast differentiation and function.

Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Goto M, Mochizuki SI, Tsuda E, Morinaga T, Udagawa N, Takahashi N, Suda T, Higashio K.

Bone. 1999 Jul;25(1):109-13.

PMID:
10423033
[PubMed - indexed for MEDLINE]
10.

Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells.

Takeuchi T, Tsuboi T, Arai M, Togari A.

Biochem Pharmacol. 2001 Mar 1;61(5):579-86.

PMID:
11239501
[PubMed - indexed for MEDLINE]
11.

Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.

Itoh K, Udagawa N, Matsuzaki K, Takami M, Amano H, Shinki T, Ueno Y, Takahashi N, Suda T.

J Bone Miner Res. 2000 Sep;15(9):1766-75.

PMID:
10976996
[PubMed - indexed for MEDLINE]
12.

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.

Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T.

J Exp Med. 2000 Jan 17;191(2):275-86.

PMID:
10637272
[PubMed - indexed for MEDLINE]
Free PMC Article
13.
14.

Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.

Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR.

Arthritis Rheum. 2000 Feb;43(2):250-8.

PMID:
10693863
[PubMed - indexed for MEDLINE]
Free Article
15.

Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis.

Tsurukai T, Udagawa N, Matsuzaki K, Takahashi N, Suda T.

J Bone Miner Metab. 2000;18(4):177-84.

PMID:
10874596
[PubMed - indexed for MEDLINE]
16.

Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function.

Jimi E, Akiyama S, Tsurukai T, Okahashi N, Kobayashi K, Udagawa N, Nishihara T, Takahashi N, Suda T.

J Immunol. 1999 Jul 1;163(1):434-42.

PMID:
10384146
[PubMed - indexed for MEDLINE]
Free Article
17.

Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation.

Tai H, Miyaura C, Pilbeam CC, Tamura T, Ohsugi Y, Koishihara Y, Kubodera N, Kawaguchi H, Raisz LG, Suda T.

Endocrinology. 1997 Jun;138(6):2372-9.

PMID:
9165025
[PubMed - indexed for MEDLINE]
18.
19.

Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.

Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ.

J Bone Miner Res. 2000 Aug;15(8):1459-66.

PMID:
10934644
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk